Replies to post #14545 on Mast Therapeutics, Inc. (MSTX)

[Pian0wire]

We've got to state facts here:

1. Their Phase 3 trial didnt show efficacy
2. They have 2 others in Phase 2
3. They have 35 MILLION in cash!
4. They are paying a 10 million payment toward debt, which will leave them only 3.2 million in debt.
5. They will have betwee 20-25 MILLION in CASH on hand after that initial payment.

....looks like they're doing ok to me. On cash value ALONE, this is undervalued.

The stock is also waaay oversold.

Let's stick to honest statements. Good day.